ACCOUNT WINS

Stonefly Communications Group has been chosen as agency of record for Novo Nordisk's Novo-Seven Coagulation Factor Vila, a treatment for bleeding episodes in hemophilia patients. The assignment will include brand development, strategic planning as well as physician and patient communications. Based

GSW Worldwide has been named agency of record for Roflumilast, an investigational phosphodiest-erase-4 inhibitor that is in development for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. Roflumilast is being co-developed and co-promoted in the majority of global markets by Pfizer and Altana Pharma.

Donahoe Purohit Miller, a Chicago-based marketing company, has been selected as agency of record for Tindamax (tinidazole), a new product launched by Presutti Laboratories. The product is a second-generation nitroimidazole antibacterial/antiparasitic with similar scope as metronidazole.Tindamax recently received approval from the FDA as a first-line therapy for the treatment of trichomoniasis, giardiasis, intestinal amebiasis and amebic liver abscess in adults and pediatric patients ages three and older.

The Spellman Group has been retained by Genzyme to assist with a major initiative aimed at educating pediatricians about the early signs of lysosomal storage disorders. The Cranford, N.J.-based agency will be responsible for the development and execution of a multimedia campaign involving advocacy development, advertising, collateral promotion and educational programs. Spellman also has been named agency of record by Enzon Pharmaceuticals for three of the company's leading products: Abelcet, a systemic antifungal agent, and a pair of oncology products, DepoCyt and Oncaspar.The agency will be responsible for the development and execution of advertising, promotion and educational programs related to ongoing marketing efforts.